GBT Announces Six Data Presentations on Sickle Cell Disease at Upcoming 63rd American Society of Hematology (ASH) Annual Meeting & Exposition

NEXT STORY
Allogene Therapeutics to Showcase Clinical Data from the ALPHA, ALPHA2 and UNIVERSAL AlloCAR T™ Trials at the 63rd Annual Meeting of the American Society of Hematology
PREV STORY
Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Indi Molecular Appoints Dr. Michael T. Klimas as Senior VP Strategy & Technical Business Development

CULVER CITY, Calif., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Indi Molecular, an emerging life ...

author_avatar
NASDAQ Market News

Sequana Medical to Host a Key Opinion Leader Webinar on “The Impact of Liver Ascites on Patients and Healthcare Systems and the potential of alfapump® therapy in NASH-related ascites”

author_avatar
NASDAQ Market News

Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

author_avatar
NASDAQ Market News